OvaryIt Foundation Business Plan 2026/2027

1. Executive Summary

The OvaryIt Foundation exists to increase autonomy, safety, and health access for individuals experiencing domestic violence and human trafficking. Survivors of reproductive coercion are twice as likely to face unintended pregnancy, a deliberate tactic used by perpetrators to maintain control, restrict freedom, and deepen dependency.

 

Historically, the Foundation focused on awareness, education, and limited resource distribution. Today, we are expanding our reach through a groundbreaking model: Partnering with trained, community-based pharmacists to deliver safe, discreet, accessible contraceptive care directly to vulnerable populations, with the Foundation subsidizing the cost of care.

 

This transforms both women’s shelters and local pharmacies into interconnected public health hubs for reproductive safety.

 

2. Problem Statement

Survivors of domestic violence and human trafficking face profound and often invisible barriers when seeking reproductive healthcare. For many, contraception is not merely a health decision, it is a lifeline, a means of regaining control over their bodies and their futures. Yet the systems designed to provide care frequently fail them. Traditional clinic-based models rely on stability, transportation, privacy, and autonomy; conditions that many impacted often do not have.

 

Control, fear, and surveillance shape nearly every aspect of survivors’ daily lives. These realities make accessing women’s health services not only difficult but, at times, dangerous. The result is a deeply inequitable gap in care access, particularly for contraception and emergency contraception, leaving survivors disproportionately vulnerable to unintended pregnancies. These pregnancies are not accidental; they are often the result of reproductive coercion, a deliberate strategy used by perpetrators to maintain control and dependency.

 

The OvaryIt Foundation seeks to break this cycle by creating a direct, safe, discreet, community-embedded pathway to care through trained pharmacists. This model recognizes the structural barriers survivors face and acknowledges that traditional care environments cannot meet the urgency or complexity of their needs.

 

2.1 Structural Barriers for Survivors

Survivors encounter a constellation of obstacles that make seeking women’s health services extraordinarily challenging. These barriers are not incidental, they are the direct result of abusive environments designed to limit autonomy, create dependency, and restrict access to outside support.

 

Key barriers include:

• Isolation and controlled movement
  Survivors may not be allowed to leave the home freely, may be monitored when they do, or may be required to justify every outing, making clinic visits unrealistic or unsafe.
• Confiscation of phones, IDs, or financial resources
  Without identification, a phone, or money, survivors cannot schedule appointments, verify insurance, or navigate typical healthcare systems.
• Fear that insurance claims will alert the perpetrator
  Many survivors avoid care because explanation-of-benefits (EOBs) or insurance notifications could reveal their attempt to seek contraception.
• Lack of transportation or safe travel routes
  Survivors often rely on perpetrators for transportation, making independent healthcare access impossible.
• Long wait times and limited prescriber availability
  Even when survivors find opportunities to seek care, long clinic waitlists or scheduling delays make timely access nearly unattainable.
• Fear of judgment, retaliation, or exposure
  Survivors may avoid healthcare environments due to stigma, fear of mandated reporting misunderstandings, or potential retaliation from the abuser if discovered.

Together, these barriers create a system where survivors often cannot access contraception even when they desperately want it, reinforcing the need for a discreet, community-based alternative.

 

2.2 Reproductive Coercion

Reproductive coercion is a central tactic used in abusive relationships, and it fundamentally alters how survivors experience pregnancy, contraception, and healthcare. It is not a passive phenomenon, it is an intentional strategy of control.

 

Perpetrators often engage in behaviors such as:

• Sabotaging birth control
  Hiding, destroying, or tampering with contraceptive methods to prevent their effectiveness.
• Blocking access to prescribers or clinics
  Preventing survivors from seeking appointments or refusing to allow them to take time for healthcare.
• Withholding financial or logistical support for medical care
  Not providing money, transportation, or childcare needed for a survivor to attend an appointment.
• Coercing pregnancy to reinforce dominance and dependency
  Pressuring, manipulating, or forcing pregnancy as a means of ensuring long-term control.

These tactics mean survivors face pregnancies not by choice, but by force, and they often have no safe or accessible path to prevent them. Traditional clinic models assume privacy, autonomy, and resources that survivors simply do not have. As a result, standard healthcare delivery systems cannot meet the needs of those facing reproductive coercion.

 

This is precisely why a pharmacist-led, Foundation-supported model is essential: it brings care directly into the community, reduces discovery risk, and creates a confidential access point outside the structures that perpetrators monitor or control.

 

3. Vision & Mission

Vision: A nation where every survivor has immediate, confidential access to contraception and women’s health services, without fear, judgment, or financial barrier.

 

Mission: To build a national network of pharmacists and community partners who provide low-cost, trauma-informed contraceptive care to survivors of domestic violence and human trafficking, supported by Foundation subsidies and community donations.

 

4. Program Model: “Pharmacist Public Health Hubs”

The Foundation’s program model is built on a simple but transformative idea: pharmacies can serve as immediate, discreet, community-based access points for survivors seeking contraceptive care. By structuring a partnership between the Foundation, local shelters, and trained community pharmacists, we create a scalable, trauma-informed network that meets survivors where they are, not where the system expects them to be.

 

This model reframes the pharmacy from a retail counter to a public health hub, enabling rapid access to time-sensitive care while removing many of the barriers that make traditional clinics inaccessible. The result is a coordinated, three-tier system that strengthens local safety nets and directs donor resources into direct, measurable impact.

4.1 Tiered Collaboration Structure

A. Shelter Partnerships

Shelters play a critical role as trusted, familiar environments where survivors often seek safety and support. By partnering directly with shelters, the Foundation provides tools and pathways that allow staff to confidently connect survivors with reproductive health resources.

The Foundation will:

• Supply women’s health starter kits, including emergency contraception, pregnancy tests, menstrual hygiene products, condoms, and easy-to-understand educational materials tailored for individuals experiencing reproductive coercion.
• Provide on-site informational workshops for staff and residents to increase awareness of reproductive safety, contraception options, and available pharmacy partnerships.
• Create direct referral pathways that allow shelter staff to discreetly connect survivors with trained pharmacists in the community.
• Support survivors who require transportation or silent scheduling options, ensuring logistical barriers do not prevent access.

This tier ensures shelters are equipped, empowered, and never alone in addressing survivors’ reproductive health needs.

 

B. Pharmacist Partner Network

Pharmacies are uniquely positioned to deliver fast, low-barrier, trauma-informed contraceptive care. They are accessible, trusted, widely distributed across communities, and often have extended hours compared to clinics.

We recruit pharmacies whose pharmacists:

• Are trained or certified in contraceptive prescribing as required by state law.
• Can apply trauma-informed care principles, ensuring interactions are safe, validating, and free from stigma.
• Are willing to prioritize survivors referred by local shelters, creating a protected pathway to care.

The Foundation will:

• Subsidize pharmacist reimbursement, offering a modest and predictable financial incentive ($25 per visit) to ensure sustainability without creating undue burden on the survivor.
• Offer PRISM-supported workflows that streamline secure intake, documentation, discreet communication, and e-prescribing while avoiding PHI-sharing with the Foundation.
• Provide ongoing training, resources, and technical support to maintain a high level of care and ensure consistency across partner sites.

This tier creates a dependable, geographically distributed network of safe clinical touchpoints.

 

C. Public Health Outcome Loop

The collaboration between shelters, pharmacies, and the Foundation creates a dynamic, community-embedded system that continuously improves access, safety, and outcomes.

Within this loop:

• Survivors receive safe, private contraceptive counseling and prescribing in environments that minimize risk and maximize autonomy.
• Pharmacists deliver community-based care, meeting survivors at a point of access that is near their home, shelter, or support system.
• Shelters gain reliable clinical partners, reducing the burden on staff and expanding their ability to protect survivors’ reproductive autonomy.
• The Foundation converts donations into direct clinical access, ensuring contributions fund immediate, tangible improvements in survivors’ lives rather than administrative abstractions.

This loop forms a sustainable public-health infrastructure, one that expands capacity, strengthens local ecosystems of care, and reduces the incidence of unintended pregnancies driven by coercion.

5. Value Proposition

The strength of this model lies in its ability to create meaningful value for every stakeholder involved, including survivors, pharmacies, shelters, and donors. While most create costly infrastructure models, the Foundation can leverage affordable treatment options by partnering with existing providers and infrastructure. By designing an ecosystem where each party benefits, the Foundation ensures sustainability, scalability, and long-term community impact. Survivors gain a safe and confidential pathway to essential reproductive healthcare; pharmacies expand their role as public health partners; shelters receive reliable clinical support without added burden; and donors fund a program where every contribution produces direct, measurable outcomes.

 

This alignment of incentives transforms fragmented community resources into a coordinated, trauma-informed care network. The following value statements illustrate how each stakeholder experiences tangible, mission-aligned benefit through participation in this program.

5.1 For Survivors

• Confidential access
• Fast, local care
• No insurance footprint
• No out-of-pocket cost
• Trauma-informed pharmacists
• Restored autonomy and safety

5.2 For Pharmacies

• New patient care revenue stream
• Foundation-subsidized reimbursement
• Community reputation as a safe access point
• Turnkey workflow via PRISM

5.3 For Shelters

• A dependable, vetted clinical partner
• Simplified referral workflows
• Enhanced survivor support offerings
• Reduced burden on overextended staff

5.4 For Donors

• Every dollar directly funds real clinical care
• Transparent, measurable impact
• A mission tied to human safety and dignity

 

6. Service Offerings

Through partnerships with trained pharmacists and integrated telehealth pathways, the Foundation ensures survivors have timely, confidential access to contraceptive care. These services are designed to bypass the logistical, financial, and safety challenges that make traditional healthcare settings inaccessible.

 

6.1 Contraceptive Prescribing Services

• Hormonal contraceptive prescribing: Survivors can receive same-day or next-day access to oral contraceptives, patches, rings, or injections through partnered pharmacies or telehealth visits, depending on state regulations and survivor safety considerations.
• Reproductive coercion assessment: Pharmacists are trained to screen for signs of reproductive coercion using discreet, evidence-based tools that prioritize survivor safety and autonomy.
• Safety-planning referrals: When appropriate and safe, pharmacists provide survivors with referrals to shelters, crisis hotlines, advocacy programs, and local support organizations specializing in safety planning and violence prevention.

These services allow survivors to obtain essential care without reliance on insurance, transportation, or environments monitored by perpetrators.

6.2 Women’s Health Support Services

Beyond prescription access, the Foundation delivers essential women’s health resources directly to shelters, ensuring survivors have immediate support at their point of refuge. These resources address both urgent needs and longer-term health literacy.

Service components include:

• “Women’s Safety & Health Kits” delivered to shelters: Kits are curated to provide survivors with discreet, immediate access to foundational reproductive health tools and are tailored to the realities of abuse dynamics. They include:
• Emergency contraception, providing a critical option when contraceptive sabotage or sexual assault is present.
• Pregnancy tests, allowing survivors to assess pregnancy status privately and safely.
• Menstrual health supplies, including pads, tampons, and liners, to ensure basic dignity and comfort during displacement or crisis.
• Health literacy education: The Foundation supplies shelters with clear, accessible materials that address contraception options, consent, reproductive coercion, and strategies for navigating healthcare safely. These resources are written for varied literacy levels and are available in multiple languages.
• STI education and future testing referrals: Survivors receive foundational education on STI prevention, symptoms, and care pathways. As the program expands, the Foundation will incorporate referral networks for low- or no-cost STI testing within pharmacies, clinics, or mobile services.

 

These support services reinforce safety, dignity, and bodily autonomy while addressing immediate barriers to care.

7. Financial Model

A sustainable financial model is essential to ensuring the Foundation can consistently deliver services, expand its reach, and translate donor support into measurable impact. The model is built on transparent cost centers and diversified revenue streams that together create financial stability and scalability.

7.1 Cost Centers

The Foundation’s expenditures focus on direct service delivery, program infrastructure, and the operational supports required to maintain high-quality partnerships.

Primary cost centers include:

• Pharmacy reimbursement subsidies: Fixed, predictable payments that allow survivors to access contraceptive care without cost or insurance exposure.
• Women’s health kits & educational materials: Procurement, assembly, and distribution of emergency contraception, pregnancy tests, condoms, hygiene products, and printed resources.
• Shelter partnership expenses: Staff training, on-site workshops, program coordination, and logistics associated with supporting community partners.
• Internal operations & infrastructure: Administrative staffing, technology platforms, PRISM integration, website maintenance, communications, marketing, and public awareness efforts.

7.2 Revenue Streams

To support long-term viability and reduce dependency on any single funding source, the Foundation engages a diverse set of revenue opportunities.

 

Key revenue streams include:

• Grants: Funding from government agencies, foundations, and public health initiatives.
• Corporate sponsorships: Partnerships with companies committed to women’s health, safety, or community impact.
• Individual donors: Contributions from supporters seeking to directly empower survivors.
• Philanthropic partnerships: Engagement with family foundations, charitable trusts, and mission-aligned benefactors.
• Nonprofit/For-profit collaboration programs: Joint initiatives with commercial partners that expand reach while maintaining compliance and nonprofit integrity.

7.3 Funding Strategy

The OvaryIt Foundation’s funding strategy is built on diversification, transparency, and measurable impact. Because the Foundation serves a population that is often invisible within traditional healthcare systems, and whose needs are both urgent and underfunded, our approach to financial sustainability must be both innovative and pragmatic. The strategy balances philanthropic giving, institutional funding, and mission-aligned partnerships to create a stable, resilient financial foundation capable of supporting long-term growth.

At its core, the Foundation’s value proposition offers funders something rare in the public health space: a direct, low-cost, high-impact intervention that translates every dollar into tangible, measurable access to care. The simplicity of the pharmacist reimbursement model, combined with the scalability of community-based delivery, enables the Foundation to expand services rapidly while maintaining strict cost controls. This efficiency forms the backbone of our funding narrative.

The funding strategy rests on four pillars:

1. Institutional Grant Funding: The Foundation seeks to secure support from government agencies, public health entities, and private foundations that prioritize women’s health, domestic violence prevention, reproductive justice, and community-based care. Because the program is deeply aligned with national priorities, such as increasing access to contraception, reducing unintended pregnancy, and mitigating the impacts of gender-based violence, the Foundation is positioned to compete effectively for multi-year grants. These funds will support expansion into new regions, training initiatives, evaluation and research partnerships, and core operating capacity.

2. Corporate Partnerships and Sponsorships: Businesses committed to community health, women’s empowerment, or social responsibility offer a powerful avenue for sustainable funding. The Foundation will cultivate partnerships with healthcare companies, pharmaceutical organizations, retail corporations, and technology firms that see value in supporting the pharmacist-led care model. Sponsorship opportunities include underwriting health kits, funding specific geographic regions, or supporting program innovations. Corporate partners receive clear, transparent reporting that ties their investment to meaningful community outcomes.

3. Individual and Major Donors: The Foundation’s mission resonates deeply with individuals who care about safety, autonomy, and equitable access to healthcare. The funding strategy emphasizes storytelling, transparency, and tangible impact, ensuring donors understand exactly how their contributions support survivors. Through annual giving campaigns, targeted appeals, and donor stewardship initiatives, the Foundation will cultivate a loyal base of supporters who view their donations as direct acts of empowerment for vulnerable populations.

4. Mission-Aligned Nonprofit–For-Profit Collaborations: The Foundation will engage in strategic collaborations with organizations that amplify reach while preserving nonprofit integrity. These partnerships allow the Foundation to operate efficiently, leverage shared infrastructure, and introduce low-cost, scalable service models that make donor dollars work harder. Such collaborations also create a pathway for long-term sustainability as operational costs align with programmatic value delivered.

Across all funding streams, the Foundation maintains an unwavering commitment to transparency, fiscal responsibility, and rigorous evaluation. Regular reporting, outcome monitoring, and clear communication ensure funders see the direct connection between their investment and improved health outcomes for survivors. As the Foundation expands its network of shelters and pharmacies, this diversified funding model will support national scalability while preserving the core mission: to restore autonomy, safety, and reproductive choice to those who need it most.

Milestone-Based Expansion Commitment
OvaryIt Foundation’s expansion model is milestone-based. We move to the next phase only when quantitative impact, operational capacity, and funding runway demonstrate readiness. Each phase is financially gated by committed investment, safeguarding against growth that outpaces sustainability.

 

Phase Advancement Criteria Include:

• Verified cost per survivor served and per clinical encounter
• Demonstrated demand and positive survivor + partner outcomes
• Staffing and operational infrastructure in place to support expansion
• Funded program runway secured for the next 12 months

This disciplined approach ensures donor contributions fund active services and measurable outcomes, while maintaining long-term financial sustainability.

8. Implementation

Phase 1: Pilot (First 180 Days)

The pilot stage focuses on validating the model in a controlled environment, establishing early partnerships, and gathering the baseline data needed to demonstrate feasibility and effectiveness.

Key objectives include:

• Recruit 5–10 pharmacies willing to serve as early partners and refine workflows.
• Formalize partnerships with 3-5 new shelters, enabling distribution of women’s safety kits and establishing referral pathways.
• Begin baseline data collection, including appointment volume, survivor engagement patterns, kit utilization, and operational feasibility insights.

This phase provides proof-of-concept and ensures the model is operationally sound before expansion.

Phase 2: Regional Expansion (Months 6–12)

With the model validated and early learnings incorporated, the program expands across regions to build density, strengthen networks, and prepare for multi-state operations.

Key objectives include:

• Expand the pharmacist network to 20–50 partners, increasing regional access points.
• Onboard additional shelters across multiple states, increasing survivor reach.
• Implement basic research and evaluation activities, such as satisfaction surveys, process metrics, and non-PHI utilization data.
• Launch donor-facing transparency dashboards to visually demonstrate impact, building trust and deepening fundraising engagement.

This phase establishes a robust, data-informed regional footprint.

Phase 3: National Scaling (Year 2+)

The final phase positions the Foundation as a national leader in pharmacy-based reproductive care for survivors. This stage emphasizes system coordination, policy influence, and expanded service offerings.

Key objectives include:

• Grow to 200+ pharmacists across a multi-state network, ensuring broad geographic access.
• Build interconnected shelter partnerships nationwide, creating a coordinated referral ecosystem.
• Expand the scope of women’s health offerings, including STI education, menstrual health support, and advanced contraceptive counseling.
• Engage in policy advocacy, public health partnerships, and survivor-centered legislative initiatives, reinforcing the program’s long-term sustainability and systemic impact.

This phase transforms the initiative from a regional intervention into a national public health infrastructure.

8.1 Operational Capacity & Staffing Plan

The OvaryIt Foundation is intentionally lean during its pilot phase to maximize efficiency and validate demand before committing to long-term overhead costs. Operational capacity will scale in a phased model, with staffing added only when milestone-based funding and service utilization demonstrate readiness.

 

Current Operational Model (Phase 1 Pilot)

• Core leadership executes all program activities during early implementation
• Administrative support provided through shared OvaryIt infrastructure
• Consultants utilized on a limited basis for clinical and technical enhancements
  (No full-time hires required during pilot)

 

Milestone-Based Staffing Expansion

• As volume increases and multi-site partnerships activate, dedicated staff roles will be introduced only when grant commitments are secured
• Staffing additions directly align with survivor safety, partner training, and quality assurance requirements

Phase	Operational Execution	Staffing Trigger	Planned Additions
Phase 1 – Pilot (0–6 months)	Leadership-led execution	Proof of concept + first grant secured	None
Phase 2 – Regional Expansion (6–18 months)	Growing partner network	≥500 encounters + 12-month runway committed	Program Manager + Training Lead
Phase 3 – National Scale (Year 2+)	Multi-state operations	≥1,500 encounters + multi-year funding secured	Regional Program Coordinators + Evaluation Specialist

 

 

8.2 Partner Quality & Safety 

All partners receive standardized onboarding, annual recertification, and trauma-informed training to ensure:

• Appointment access within 72 hours of referral
• Consistent service delivery quality
• Safety protocols supported jointly by pharmacies and shelters

 

This operational approach protects program continuity while demonstrating responsible stewardship of donor funds. The Foundation scales its team only when it is financially and operationally prepared, strengthening funder confidence and ensuring survivor-centered care at every stage.

9. Governance & Leadership

The OvaryIt Foundation is governed by a mission-driven Board of Directors responsible for fiduciary oversight, ethical stewardship, and protection of survivor safety throughout all program activities. Our governance practices ensure transparency, accountability, and a clear separation between the nonprofit Foundation and the OvaryIt technology platform, while still leveraging shared infrastructure to expand impact efficiently.

 

Board Structure
The Board includes leaders with expertise in trauma-informed care, reproductive health, clinical operations, nonprofit finance, legal compliance, and technology. As the Foundation grows, we will expand Board membership to ensure geographic diversity and representation of lived-experience perspectives.

 

Name	Title
Mary Kucek	Founder/CEO
Devin Bustin	Medical Oversight
Lissette Logan	COO
Todd Bartos	Legal Oversight

 

Governance Policies
The Foundation adheres to policies that protect survivors and uphold nonprofit accountability, including:

• Conflict-of-interest and nonprofit/for-profit separation
• Survivor data privacy and confidentiality standards
• Ethical and trauma-informed care principles
• Financial controls and grant compliance procedures
  
  

Advisory Committees- Coming soon
To support program excellence and community-centered design, the Foundation will establish advisory committees during Phase 2. This allows Foundation to complete the pilot program and obtain lessons learned before continued expansion:

• Survivor Advisory Council: provides insight into safety, autonomy, and accessibility
• Clinical Advisory Group: ensures evidence-based practice and quality standards
  This governance structure supports sustainable growth, strengthens funder trust, and ensures high-quality delivery of confidential reproductive care for survivors nationwide.

10. Metrics & Outcomes

Measuring impact is essential to ensuring accountability, continuous improvement, and responsible stewardship of donor resources. The OvaryIt Foundation tracks outcomes that reflect direct access to care, program reliability, and community trust, while intentionally avoiding the collection of protected health information (PHI). Metrics are designed to balance rigor with survivor safety and partner feasibility.

 

10.1 Core Output Metrics

These indicators measure program activity and reach.

·       Number of individuals receiving clinical encounters: Tracks survivor access to contraceptive counseling and prescribing through partner pharmacies, reported in aggregate and without identifying information.

·       Number of contraceptive-related appointments completed: Captures utilization volume across pharmacy and shelter-based settings to assess demand and capacity.

·       Distribution of Women’s Safety & Health Kits: Measures the number of kits delivered to shelters and distributed to survivors, including category-level counts (e.g., EC included, pregnancy tests, menstrual supplies).

·       Shelter partnerships activated: Tracks the number of shelters actively referring survivors and participating in educational or referral programming.

10.2 Quality & Program Integrity Metrics

These indicators ensure services remain timely, safe, and trauma-informed.

·       Appointment timeliness: Percentage of referrals resulting in an appointment within 72 hours, reflecting responsiveness for time-sensitive care.

·       Pharmacy partner retention rate: Measures sustainability of the pharmacist network and satisfaction with reimbursement, workflow, and Foundation support.

·       Shelter satisfaction scores: Collected through periodic, non-identifying feedback surveys assessing ease of referral, survivor experience, and perceived program value.

·       Protocol adherence: Annual verification that partner pharmacies complete required training, reporting, and trauma-informed care standards.

10.3 Survivor-Centered Outcome Indicators

While protecting anonymity, the Foundation evaluates indicators that reflect survivor autonomy and safety.

·       Reported ability to access care discreetly: Aggregated feedback from shelters and partners on whether survivors were able to obtain care without insurance, financial exposure, or increased risk.

·       Continuation of care pathways: When appropriate, tracks referrals to ongoing support services (e.g., shelters, advocacy programs, follow-up care), without monitoring individual outcomes.

·       Reduction in emergency-only access patterns: Over time, evaluates whether early contraceptive access reduces reliance on crisis-driven interventions.

10.4 Donor Transparency & Reporting

To maintain trust and accountability, the Foundation commits to:

·       Semi-Annual impact summaries detailing services delivered, partnerships activated, and funds deployed.

·       Donor-facing dashboards displaying aggregate metrics such as cost per encounter, geographic reach, and growth over time.

·       Annual program evaluation summaries highlighting lessons learned, improvements made, and expansion readiness.

All reporting prioritizes survivor safety, data minimization, and ethical use of information.